메뉴 건너뛰기




Volumn 64, Issue 2, 2013, Pages 127-133

Costs of a public health model to increase receipt of hepatitis-related services for persons with mental illness

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH SERVICE; HEPATITIS; HEPATITIS A; HEPATITIS B; HEPATITIS C; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MENTAL DISEASE; MENTAL HEALTH SERVICE; MENTAL PATIENT; OUTCOME ASSESSMENT; PATIENT COUNSELING; PUBLIC HEALTH; SUBSTANCE ABUSE; ADOLESCENT; ADULT; AFRICAN AMERICAN; AGED; AMBULATORY CARE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; COUNSELING; ECONOMICS; HEALTH CARE QUALITY; MALE; MASS SCREENING; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PATIENT EDUCATION; PSYCHIATRIC DIAGNOSIS; RANDOMIZED CONTROLLED TRIAL; URBAN POPULATION; VACCINATION; VIRUS HEPATITIS;

EID: 84880167843     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/appi.ps.000852011     Document Type: Article
Times cited : (4)

References (37)
  • 1
    • 27944492333 scopus 로고    scopus 로고
    • Hepatitis C virus and HIV coinfection in people with severe mental illness and substance use disorders
    • Rosenberg SD, Drake RE, Brunette MF, et al: Hepatitis C virus and HIV coinfection in people with severe mental illness and substance use disorders. AIDS 19 (suppl 3):S26-S33, 2005
    • (2005) AIDS , vol.19 , Issue.SUPPL. 3
    • Rosenberg, S.D.1    Drake, R.E.2    Brunette, M.F.3
  • 2
    • 0037223797 scopus 로고    scopus 로고
    • Prevalence of hepatitis C among psychiatric patients in the public sector
    • Dinwiddie SH, Shicker L, Newman T: Prevalence of hepatitis C among psychiatric patients in the public sector. American Journal of Psychiatry 160:172-174, 2003
    • (2003) American Journal of Psychiatry , vol.160 , pp. 172-174
    • Dinwiddie, S.H.1    Shicker, L.2    Newman, T.3
  • 3
    • 0035163889 scopus 로고    scopus 로고
    • Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness
    • Rosenberg SD, Goodman LA, Osher FC, et al: Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. American Journal of Public Health 91:31-37, 2001
    • (2001) American Journal of Public Health , vol.91 , pp. 31-37
    • Rosenberg, S.D.1    Goodman, L.A.2    Osher, F.C.3
  • 4
    • 27644482032 scopus 로고    scopus 로고
    • Predictors of HIV and hepatitis testing and related service utilization among individuals with serious mental illness
    • Goldberg RW, Himelhoch S, Kreyenbuhl J, et al: Predictors of HIV and hepatitis testing and related service utilization among individuals with serious mental illness. Psychosomatics 46:573-577, 2005
    • (2005) Psychosomatics , vol.46 , pp. 573-577
    • Goldberg, R.W.1    Himelhoch, S.2    Kreyenbuhl, J.3
  • 5
    • 2642551432 scopus 로고    scopus 로고
    • The STIRR model of best practices for blood-borne diseases among clients with serious mental illness
    • Rosenberg S, Brunette M, Oxman T, et al: The STIRR model of best practices for blood-borne diseases among clients with serious mental illness. Psychiatric Services 55:660-664, 2004
    • (2004) Psychiatric Services , vol.55 , pp. 660-664
    • Rosenberg, S.1    Brunette, M.2    Oxman, T.3
  • 6
    • 58149399354 scopus 로고    scopus 로고
    • Effects of a nurse-managed program on hepatitis A and B vaccine completion among homeless adults
    • Nyamathi A, Liu Y, Marfisee M, et al: Effects of a nurse-managed program on hepatitis A and B vaccine completion among homeless adults. Nursing Research 58: 13-22, 2009
    • (2009) Nursing Research , vol.58 , pp. 13-22
    • Nyamathi, A.1    Liu, Y.2    Marfisee, M.3
  • 7
    • 0035069292 scopus 로고    scopus 로고
    • Implementing dual diagnosis services for clients with severe mental illness
    • Drake RE, Essock SM, Shaner A, et al: Implementing dual diagnosis services for clients with severe mental illness. Psychiatric Services 52:469-476, 2001
    • (2001) Psychiatric Services , vol.52 , pp. 469-476
    • Drake, R.E.1    Essock, S.M.2    Shaner, A.3
  • 8
    • 16844384955 scopus 로고    scopus 로고
    • Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users
    • Edlin BR, Kresina TF, Raymond DB, et al: Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clinical Infectious Diseases 40(suppl 5):S276-S285, 2005
    • (2005) Clinical Infectious Diseases , vol.40 , Issue.SUPPL. 5
    • Edlin, B.R.1    Kresina, T.F.2    Raymond, D.B.3
  • 9
    • 33646852746 scopus 로고    scopus 로고
    • The prevalence of hepatitis C virus infection in the United States, 1999 through 2002
    • Armstrong GL, Wasley A, Simard EP, et al: The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Annals of Internal Medicine 144:705-714, 2006
    • (2006) Annals of Internal Medicine , vol.144 , pp. 705-714
    • Armstrong, G.L.1    Wasley, A.2    Simard, E.P.3
  • 10
    • 0029680124 scopus 로고    scopus 로고
    • Prevalence of HIV infection in the United States, 1984 to 1992
    • Karon JM, Rosenberg PS, McQuillan G, et al: Prevalence of HIV infection in the United States, 1984 to 1992. JAMA 276: 126-131, 1996
    • (1996) JAMA , vol.276 , pp. 126-131
    • Karon, J.M.1    Rosenberg, P.S.2    McQuillan, G.3
  • 11
    • 1642342042 scopus 로고    scopus 로고
    • Hepatitis and HIV screening, education, and treatment for adults with serious mental illness
    • Goldberg RW: Hepatitis and HIV screening, education, and treatment for adults with serious mental illness. General Hospital Psychiatry 26:167-168, 2004
    • (2004) General Hospital Psychiatry , vol.26 , pp. 167-168
    • Goldberg, R.W.1
  • 12
    • 57849093555 scopus 로고    scopus 로고
    • Hepatitis C services and individuals with serious mental illness
    • Goldberg RW, Seth P: Hepatitis C services and individuals with serious mental illness. Community Mental Health Journal 44: 381-384, 2008
    • (2008) Community Mental Health Journal , vol.44 , pp. 381-384
    • Goldberg, R.W.1    Seth, P.2
  • 13
    • 33646467688 scopus 로고    scopus 로고
    • Hepatitis B vaccination coverage among adults - United States, 2004
    • Hepatitis B vaccination coverage among adults - United States, 2004. Morbidity and Mortality Weekly Report 55:509-511, 2006
    • (2006) Morbidity and Mortality Weekly Report , vol.55 , pp. 509-511
  • 14
    • 77956871381 scopus 로고    scopus 로고
    • Receipt of preventive medical care and medical screening for patients with mental illness: A comparative analysis
    • Lord O, Malone D, Mitchell AJ: Receipt of preventive medical care and medical screening for patients with mental illness: a comparative analysis. General Hospital Psychiatry 32:519-543, 2010
    • (2010) General Hospital Psychiatry , vol.32 , pp. 519-543
    • Lord, O.1    Malone, D.2    Mitchell, A.J.3
  • 15
    • 0036479899 scopus 로고    scopus 로고
    • Quality of preventive medical care for patients with mental disorders
    • Druss BG, Rosenheck RA, Desai MM, et al: Quality of preventive medical care for patients with mental disorders. Medical Care 40:129-136, 2002
    • (2002) Medical Care , vol.40 , pp. 129-136
    • Druss, B.G.1    Rosenheck, R.A.2    Desai, M.M.3
  • 16
    • 0030070085 scopus 로고    scopus 로고
    • The course, treatment, and outcome of substance disorder in persons with severe mental illness
    • Drake RE, Mueser KT, Clark RE, et al: The course, treatment, and outcome of substance disorder in persons with severe mental illness. American Journal of Orthopsychiatry 66:42-51, 1996
    • (1996) American Journal of Orthopsychiatry , vol.66 , pp. 42-51
    • Drake, R.E.1    Mueser, K.T.2    Clark, R.E.3
  • 18
    • 73949110936 scopus 로고    scopus 로고
    • The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements
    • Dixon LB, Dickerson F, Bellack AS, et al: The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophrenia Bulletin 36:48-70, 2010
    • (2010) Schizophrenia Bulletin , vol.36 , pp. 48-70
    • Dixon, L.B.1    Dickerson, F.2    Bellack, A.S.3
  • 19
    • 73549125232 scopus 로고    scopus 로고
    • Current strategies and barriers in integrated health care: A survey of publicly funded providers in Texas
    • Sanchez K, Thompson S, Alexander L: Current strategies and barriers in integrated health care: a survey of publicly funded providers in Texas. General Hospital Psychiatry 32:26-32, 2010
    • (2010) General Hospital Psychiatry , vol.32 , pp. 26-32
    • Sanchez, K.1    Thompson, S.2    Alexander, L.3
  • 20
    • 85047688903 scopus 로고    scopus 로고
    • Assessing the STIRR model of best practices for blood-borne infections of clients with severe mental illness
    • Rosenberg SD, Goldberg RW, Dixon LB, et al: Assessing the STIRR model of best practices for blood-borne infections of clients with severe mental illness. Psychiatric Services 61:885-891, 2010
    • (2010) Psychiatric Services , vol.61 , pp. 885-891
    • Rosenberg, S.D.1    Goldberg, R.W.2    Dixon, L.B.3
  • 21
    • 0027513311 scopus 로고
    • A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis
    • Bloom BS, Hillman AL, Fendrick AM, et al: A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis. Annals of Internal Medicine 118: 298-306, 1993
    • (1993) Annals of Internal Medicine , vol.118 , pp. 298-306
    • Bloom, B.S.1    Hillman, A.L.2    Fendrick, A.M.3
  • 22
    • 0037355189 scopus 로고    scopus 로고
    • A review of the case for hepatitis B vaccination of high-risk adults
    • Rich JD, Ching CG, Lally MA, et al: A review of the case for hepatitis B vaccination of high-risk adults. American Journal of Medicine 114:316-318, 2003
    • (2003) American Journal of Medicine , vol.114 , pp. 316-318
    • Rich, J.D.1    Ching, C.G.2    Lally, M.A.3
  • 23
    • 85044710392 scopus 로고    scopus 로고
    • The cost-effectiveness of testing for hepatitis C in former injecting drug users
    • ix-xii, 1-93
    • Castelnuovo E, Thompson-Coon J, Pitt M, et al: The cost-effectiveness of testing for hepatitis C in former injecting drug users. Health Technology Assessment 10:iii-iv, ix-xii, 1-93, 2006
    • (2006) Health Technology Assessment , vol.10
    • Castelnuovo, E.1    Thompson-Coon, J.2    Pitt, M.3
  • 24
    • 33745684322 scopus 로고    scopus 로고
    • Hepatitis C: Cost of illness and considerations for the economic evaluation of antiviral therapies
    • Wong JB: Hepatitis C: cost of illness and considerations for the economic evaluation of antiviral therapies. PharmacoEconomics 24:661-672, 2006
    • (2006) PharmacoEconomics , vol.24 , pp. 661-672
    • Wong, J.B.1
  • 25
    • 33646426438 scopus 로고    scopus 로고
    • Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites
    • Kim SY, Billah K, Lieu TA, et al: Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites. American Journal of Preventive Medicine 30:498-506, 2006
    • (2006) American Journal of Preventive Medicine , vol.30 , pp. 498-506
    • Kim, S.Y.1    Billah, K.2    Lieu, T.A.3
  • 26
    • 0032433812 scopus 로고    scopus 로고
    • Hepatitis B vaccination of adolescent and adult high-risk groups in the United States
    • Mast EE, Williams IT, Alter MJ, et al: Hepatitis B vaccination of adolescent and adult high-risk groups in the United States. Vaccine 16(suppl):S27-S29, 1998
    • (1998) Vaccine , vol.16 , Issue.SUPPL.
    • Mast, E.E.1    Williams, I.T.2    Alter, M.J.3
  • 27
    • 58249122590 scopus 로고    scopus 로고
    • Cost-effectiveness analysis of behavioral interventions to improve vaccination compliance in homeless adults
    • Greengold B, Nyamathi A, Kominski G, et al: Cost-effectiveness analysis of behavioral interventions to improve vaccination compliance in homeless adults. Vaccine 27: 718-725, 2009
    • (2009) Vaccine , vol.27 , pp. 718-725
    • Greengold, B.1    Nyamathi, A.2    Kominski, G.3
  • 28
    • 13444270732 scopus 로고    scopus 로고
    • Expanded screening for HIV in the United States - An analysis of cost-effectiveness
    • Paltiel AD, Weinstein MC, Kimmel AD, et al: Expanded screening for HIV in the United States - an analysis of cost-effectiveness. New England Journal of Medicine 352:586-595, 2005
    • (2005) New England Journal of Medicine , vol.352 , pp. 586-595
    • Paltiel, A.D.1    Weinstein, M.C.2    Kimmel, A.D.3
  • 29
    • 1542358091 scopus 로고    scopus 로고
    • Screening for hepatitis C virus infection: A review of the evidence for the US Preventive Services Task Force
    • Chou R, Clark EC, Helfand M: Screening for hepatitis C virus infection: a review of the evidence for the US Preventive Services Task Force. Annals of Internal Medicine 140:465-479, 2004
    • (2004) Annals of Internal Medicine , vol.140 , pp. 465-479
    • Chou, R.1    Clark, E.C.2    Helfand, M.3
  • 32
    • 84883072128 scopus 로고    scopus 로고
    • Hanover, NH, Dartmouth College C, Everett Koop Institute. Accessed July 17, 2011
    • Hepatitis C: An Epidemic for Everyone. Hanover, NH, Dartmouth College, C Everett Koop Institute, 2012. Available at www.epidemic.org/theFacts/ theEpidemic/USHealthCareCosts.php. Accessed July 17, 2011
    • (2012) An Epidemic for Everyone
  • 33
    • 78650021698 scopus 로고    scopus 로고
    • Recent advances in hepatitis C virus treatment: Review of HCV protease inhibitor clinical trials
    • Chary A, Holodniy M: Recent advances in hepatitis C virus treatment: review of HCV protease inhibitor clinical trials. Reviews on Recent Clinical Trials 5:158-173, 2010
    • (2010) Reviews on Recent Clinical Trials , vol.5 , pp. 158-173
    • Chary, A.1    Holodniy, M.2
  • 34
    • 77956268467 scopus 로고    scopus 로고
    • Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): An open-label, randomised, multicentre phase 2 trial
    • Kwo PY, Lawitz EJ, McCone J, et al: Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial. Lancet 376:705-716, 2010
    • (2010) Lancet , vol.376 , pp. 705-716
    • Kwo, P.Y.1    Lawitz, E.J.2    McCone, J.3
  • 35
    • 65449152185 scopus 로고    scopus 로고
    • Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection
    • McHutchison JG, Everson GT, Gordon SC, et al: Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection. New England Journal of Medicine 360:1827-1838, 2009
    • (2009) New England Journal of Medicine , vol.360 , pp. 1827-1838
    • McHutchison, J.G.1    Everson, G.T.2    Gordon, S.C.3
  • 36
    • 80051633217 scopus 로고    scopus 로고
    • Prevention of HIV-1 infection with early antiretroviral therapy
    • Cohen MS, Chen YQ, McCauley M, et al: Prevention of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine 365:493-505, 2011
    • (2011) New England Journal of Medicine , vol.365 , pp. 493-505
    • Cohen, M.S.1    Chen, Y.Q.2    McCauley, M.3
  • 37
    • 33644780945 scopus 로고    scopus 로고
    • Hepatitis C treatment for people with severe mental illness
    • Mistler LA, Brunette MF, Marsh BJ, et al: Hepatitis C treatment for people with severe mental illness. Psychosomatics 47: 93-107, 2006
    • (2006) Psychosomatics , vol.47 , pp. 93-107
    • Mistler, L.A.1    Brunette, M.F.2    Marsh, B.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.